69 related articles for article (PubMed ID: 6413582)
1. The modeled structure of the IgG Gar VL region and its implications for anti-flavin and anti-DNP fine specificities.
Kiefer CR; McGuire BS; Osserman EF; Garver FA
J Immunol; 1983 Oct; 131(4):1871-5. PubMed ID: 6413582
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic dissection of a hapten binding site.
Sen J; Beychok S
Proteins; 1986 Nov; 1(3):256-62. PubMed ID: 3130623
[TBL] [Abstract][Full Text] [Related]
3. Repertoire of murine lambda-positive variable domains: polyclonal induction of lambda isotypes and their associated pattern of antibody specificities.
Sanchez P; Cazenave PA
Eur J Immunol; 1986 Aug; 16(8):895-900. PubMed ID: 3091376
[TBL] [Abstract][Full Text] [Related]
4. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
Frangione B; Moloshok T; Solomon A
J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
[TBL] [Abstract][Full Text] [Related]
5. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
[TBL] [Abstract][Full Text] [Related]
6. Anti-V region framework antibodies affect the ligand binding of VL dimer.
Ben-Neriah Y; Givol D; Gavish M
Eur J Immunol; 1979 Jan; 9(1):91-3. PubMed ID: 108113
[TBL] [Abstract][Full Text] [Related]
7. Mouse myeloma proteins with lambda 2 and lambda 3 light chains.
Cotner T; Blaser K; Kriedberg J; Potter M; Eisen HN
J Immunol; 1981 Nov; 127(5):2150-5. PubMed ID: 6795267
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the N-terminal amino acid sequences of early and late pools of anti-DNP and anti-DNP-p-aminobenzoylglutamate antibody light chains.
Hagins DM; Bray VH; Henke J; Lovins RE
Immunology; 1978 May; 34(5):853-61. PubMed ID: 96009
[TBL] [Abstract][Full Text] [Related]
9. Chemical and serologic characterization of human lambda VIII light chains.
Solomon A; Weiss DT; Murphy C; Fu SM; Robbins DL
J Immunol; 1994 Aug; 153(4):1658-64. PubMed ID: 8046238
[TBL] [Abstract][Full Text] [Related]
10. Distinctive serologic, chemical, and molecular properties of human lambda IV light chains.
Eulitz M; Ch'ang LY; Zirkel C; Schell M; Weiss DT; Solomon A
J Immunol; 1995 Apr; 154(7):3256-65. PubMed ID: 7897210
[TBL] [Abstract][Full Text] [Related]
11. Amino acid sequence diversity in mouse lambda 2 variable regions.
Elliott BW; Eisen HN; Steiner LA
J Immunol; 1984 Nov; 133(5):2757-61. PubMed ID: 6434637
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of human lambda I variable regions with a monoclonal antibody to a defined, germ-line-encoded idiotope correlates with V lambda Ia chemical structure.
Suleyman S; Hosono O; Sioud M; Randen I; Thompson KM; Førre O; Natvig JB
J Immunol; 1993 Jun; 150(12):5466-75. PubMed ID: 8515071
[TBL] [Abstract][Full Text] [Related]
13. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
[TBL] [Abstract][Full Text] [Related]
14. A third Ig light chain gene isotype in Xenopus laevis consists of six distinct VL families and is related to mammalian lambda genes.
Haire RN; Ota T; Rast JP; Litman RT; Chan FY; Zon LI; Litman GW
J Immunol; 1996 Aug; 157(4):1544-50. PubMed ID: 8759737
[TBL] [Abstract][Full Text] [Related]
15. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
16. The primary structure of a human lambda II chain.
Köhler H; Rudofsky S; Kluskens L
J Immunol; 1975 Jan; 114(1 Pt 2):415-21. PubMed ID: 804002
[TBL] [Abstract][Full Text] [Related]
17. A V lambda x-bearing monoclonal antibody with similar specificity and sequence to encephalitogenic T cell receptors.
Maier CC; Galin FS; Jarpe MA; Jackson P; Krishna NR; Gautam AM; Zhou SR; Whitaker JN; Blalock JE
J Immunol; 1994 Aug; 153(3):1132-40. PubMed ID: 7517973
[TBL] [Abstract][Full Text] [Related]
18. T cell regulation of light chain expression: preferential enhancement of Ig kappa in a primary thymus-dependent response does not require affinity-based selection.
Burkly LC; Nikolic J; Wortis HH
J Immunol; 1985 Sep; 135(3):1573-6. PubMed ID: 3926878
[TBL] [Abstract][Full Text] [Related]
19. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
[TBL] [Abstract][Full Text] [Related]
20. Requirement for both H and L chain V regions, VH and VK joining amino acids, and the unique H chain D region for the high affinity binding of an anti-phosphotyrosine antibody.
Ruff-Jamison S; Glenney JR
J Immunol; 1993 Apr; 150(8 Pt 1):3389-96. PubMed ID: 7682239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
